BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22805619)

  • 1. A primer on the epigenetics of kidney fibrosis.
    Tampe D; Zeisberg M
    Minerva Med; 2012 Aug; 103(4):267-78. PubMed ID: 22805619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of genetics and epigenetics to progression of kidney fibrosis.
    Tampe B; Zeisberg M
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv72-9. PubMed ID: 23975750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Idiopathic chronic tubulointerstitial nephritis].
    Kumagai H; Hatama S; Yoshimitsu T
    Nihon Rinsho; 1995 Aug; 53(8):2057-63. PubMed ID: 7563650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unravelling fibrosis: two newcomers and an old foe.
    Ortiz A; Ucero AC; Egido J
    Nephrol Dial Transplant; 2010 Nov; 25(11):3492-5. PubMed ID: 20833689
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms of tubulointerstitial fibrosis.
    Zeisberg M; Neilson EG
    J Am Soc Nephrol; 2010 Nov; 21(11):1819-34. PubMed ID: 20864689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel therapeutic strategy with hypoxia-inducible factors via reversible epigenetic regulation mechanisms in progressive tubulointerstitial fibrosis.
    Mimura I; Tanaka T; Nangaku M
    Semin Nephrol; 2013 Jul; 33(4):375-82. PubMed ID: 24011579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines in epithelial-mesenchymal transition: a new insight into obstructive nephropathy.
    Bani-Hani AH; Campbell MT; Meldrum DR; Meldrum KK
    J Urol; 2008 Aug; 180(2):461-8. PubMed ID: 18550128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of tubulointerstitial changes in progression of kidney function failure in patients with chronic glomerulonephritis (GN)].
    Idasiak-Piechocka I; Krzymański M
    Przegl Lek; 1996; 53(5):443-53. PubMed ID: 8754411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of lymphocytes in the progression of interstitial disease.
    Strutz F; Neilson EG
    Kidney Int Suppl; 1994 Feb; 45():S106-10. PubMed ID: 8158876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models of renal fibrosis.
    Zeisberg M; Soubasakos MA; Kalluri R
    Methods Mol Med; 2005; 117():261-72. PubMed ID: 16118458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis.
    Ma FY; Flanc RS; Tesch GH; Han Y; Atkins RC; Bennett BL; Friedman GC; Fan JH; Nikolic-Paterson DJ
    J Am Soc Nephrol; 2007 Feb; 18(2):472-84. PubMed ID: 17202416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor.
    Choi YJ; Chakraborty S; Nguyen V; Nguyen C; Kim BK; Shim SI; Suki WN; Truong LD
    Hum Pathol; 2000 Dec; 31(12):1491-7. PubMed ID: 11150374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetics of kidney diseases and renal fibrosis].
    Grünfeld JP; Chauveau D; Joly D; Oualim Z
    Bull Acad Natl Med; 1999; 183(1):57-63. PubMed ID: 10371765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epigenetic conductor: a genomic orchestrator in chronic kidney disease complications?
    Ekström TJ; Stenvinkel P
    J Nephrol; 2009; 22(4):442-9. PubMed ID: 19662598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New therapies and new pathologies: end-stage--dialysis kidneys.
    McManus JF; Hughson MD
    Arch Pathol Lab Med; 1979 Feb; 103(2):53-7. PubMed ID: 369473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into molecular mechanisms of epigenetic regulation in kidney disease.
    Mimura I; Tanaka T; Nangaku M
    Clin Exp Pharmacol Physiol; 2016 Dec; 43(12):1159-1167. PubMed ID: 27560313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression fingerprints in human tubulointerstitial inflammation and fibrosis as prognostic markers of disease progression.
    Henger A; Kretzler M; Doran P; Bonrouhi M; Schmid H; Kiss E; Cohen CD; Madden S; Porubsky S; Gröne EF; Schlöndorff D; Nelson PJ; Gröne HJ
    Kidney Int; 2004 Mar; 65(3):904-17. PubMed ID: 14871410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of chronic renal disease in heart transplant recipients: importance of pretransplantation native kidney histologic evaluation.
    Lewis RM; Verani RR; Vo C; Katz SM; Van Buren CT; Radovancevic B; Kerman RH; Frazier OH; Kahan BD
    J Heart Lung Transplant; 1994; 13(3):376-80. PubMed ID: 8061012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteinuria: detection and role in native renal disease progression.
    Gorriz JL; Martinez-Castelao A
    Transplant Rev (Orlando); 2012 Jan; 26(1):3-13. PubMed ID: 22137726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tubulointerstitial injury and the progression of chronic kidney disease.
    Hodgkins KS; Schnaper HW
    Pediatr Nephrol; 2012 Jun; 27(6):901-9. PubMed ID: 21947270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.